Literature DB >> 23343552

Multifaceted hemolytic uremic syndrome in pediatrics.

Carla M Nester1.   

Abstract

Hemolytic uremic syndromes can have devastating consequences in childhood. The common feature of a microangiopathic hemolytic anemia and thrombocytopenia associated with varying degrees of renal injury often creates diagnostic confusion. The inability to arrive at a definitive diagnosis quickly can lead to a delay in initiating renal-preserving and sometimes life-saving treatment. Currently, both the treatment plan and the prognosis vary substantially according to the presumed diagnosis. The availability of anti-complement therapy makes differentiating the cause of the hemolytic uremic syndrome particularly critical. Therefore, it is imperative that consideration be given to each of the possible syndromes at presentation in order to facilitate correct diagnosis and development of an appropriate treatment strategy for both the acute phase and for the long-term care of the patient.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23343552     DOI: 10.1159/000346486

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  2 in total

1.  Complement factor B mutation-associated aHUS and myocardial infarction.

Authors:  Natália Noronha; Filipa Dias Costa; Andrea Dias; Alexandra Dinis
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome.

Authors:  Martin Kreuzer; Laura Sollmann; Stephan Ruben; Maren Leifheit-Nestler; Dagmar-Christiane Fischer; Lars Pape; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2017-02-08       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.